Skip to content
10-Q

Quarterly Report

Lantern Pharma Inc. LTRN

0001641172-25-023471

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 10.8M sh
Shares Diluted Q2 2025 · Jun 30, 2025 10.78M sh
Shares Diluted Q2 2025 · Jun 30, 2025 10.78M sh
Shares Diluted Q2 2025 · Jun 30, 2024 10.76M sh
Shares Diluted Q2 2025 · Jun 30, 2024 10.75M sh
Capex Q2 2025 · Jun 30, 2025 $1.16K
Capex Q2 2025 · Jun 30, 2024 $6.48K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$8.31M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$8.26M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $6.06M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $7.51M
Stockholders Equity Q2 2025 · Jun 30, 2025 $12.52M
Stockholders Equity Q2 2025 · Mar 31, 2025 $16.78M
Stockholders Equity Q2 2025 · Dec 31, 2024 $21.19M
Stockholders Equity Q2 2025 · Jun 30, 2024 $30.93M
Stockholders Equity Q2 2025 · Mar 31, 2024 $35.77M
Stockholders Equity Q2 2025 · Dec 31, 2023 $40.91M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.88M
Current Liabilities Q2 2025 · Dec 31, 2024 $4.33M
Total Liabilities Q2 2025 · Jun 30, 2025 $4.9M
Total Liabilities Q2 2025 · Dec 31, 2024 $4.38M
Current Assets Q2 2025 · Jun 30, 2025 $17.2M
Current Assets Q2 2025 · Dec 31, 2024 $25.25M
Total Assets Q2 2025 · Jun 30, 2025 $17.42M
Total Assets Q2 2025 · Dec 31, 2024 $25.57M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.40
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.82
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.46
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.97
Eps Basic Q2 2025 · Jun 30, 2025 −$0.40
Eps Basic Q2 2025 · Jun 30, 2025 −$0.82
Eps Basic Q2 2025 · Jun 30, 2024 −$0.46
Eps Basic Q2 2025 · Jun 30, 2024 −$0.97
Sga Expense Q2 2025 · Jun 30, 2025 $1.58M
Sga Expense Q2 2025 · Jun 30, 2025 $3.09M
Sga Expense Q2 2025 · Jun 30, 2024 $1.52M
Sga Expense Q2 2025 · Jun 30, 2024 $3M
Rd Expense Q2 2025 · Jun 30, 2025 $3.07M
Rd Expense Q2 2025 · Jun 30, 2025 $6.33M
Rd Expense Q2 2025 · Jun 30, 2024 $3.89M
Rd Expense Q2 2025 · Jun 30, 2024 $8.14M
Net Income Q2 2025 · Jun 30, 2025 −$4.33M
Net Income Q2 2025 · Jun 30, 2025 −$8.87M
Net Income Q2 2025 · Mar 31, 2025 −$4.54M
Net Income Q2 2025 · Jun 30, 2024 −$4.96M
Net Income Q2 2025 · Jun 30, 2024 −$10.4M
Net Income Q2 2025 · Mar 31, 2024 −$5.44M
Operating Income Q2 2025 · Jun 30, 2025 −$4.65M
Operating Income Q2 2025 · Jun 30, 2025 −$9.43M
Operating Income Q2 2025 · Jun 30, 2024 −$5.41M
Operating Income Q2 2025 · Jun 30, 2024 −$11.14M